In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa, who has ...

Sen. Brandon Shippy, R - New Plymouth, introduced two new bills last week - the Prenatal Equal Protection Act and S1036: ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

groninger, a German manufacturer of filling and closing machines for the pharmaceutical, consumer healthcare and cosmetics industries, is expanding its U.S. headquarters in Charlotte. groninger USA ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

GeneDX Holdings reports Q4 earnings on February 18th. Find out why WGS stock is a strong play in the booming genetics testing ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

The Professor of Genetics sat down with Fifteen Minutes to discuss anti-aging research, the wellness industry, and his ...

Dr. Eric Levine’s cutting-edge autism research at UConn School of Medicine is reprogramming the donated skin or blood cells ...

Raymond James resumed coverage of Regenxbio (RGNX) with an Outperform rating and $27 price target The firm expects the launch of Elevidys and ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...